Health Canada drug identification number

DIN 01962728 — ULTRAVATE 0.05 %

ULTRAVATE is a ointment of Halobetasol Propionate marketed by BAUSCH HEALTH, CANADA INC.. The full Halobetasol Propionate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
01962728
Brand name
ULTRAVATE
Active ingredient
Halobetasol Propionate
Strength
0.05 %
Dosage form
OINTMENT
Route
TOPICAL
Manufacturer
BAUSCH HEALTH, CANADA INC.
Health Canada status
MARKETED
Drug class
Superpotent topical corticosteroid

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Halobetasol Propionate products

DINBrandStrengthFormManufacturerStatus
02506262 BRYHALI 0.01 % LOTION BAUSCH HEALTH, CANADA INC. MARKETED
01962701 ULTRAVATE 0.05 % CREAM BAUSCH HEALTH, CANADA INC. MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.